Medical Economics November 25, 2024
Key Takeaways
- GLP-1 receptor agonists are proving effective in reducing body mass index and enhancing patient health outcomes.
- Patients are increasingly interested in understanding the benefits and mechanisms of these antiobesity medications.
- Dr. Robert Kushner has significantly contributed to obesity research and treatment, focusing on nutrition and lifestyle medicine.
- Northwestern University’s Feinberg School of Medicine and the Center for Lifestyle Medicine are key institutions in advancing obesity treatment.
A physician researcher and author discusses...
Today's Sponsors
Today's Sponsor